354 related articles for article (PubMed ID: 31134443)
41. Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
Chung K; Strange G; Codde J; Celermajer D; Scalia GM; Playford D
Heart Lung Circ; 2018 Mar; 27(3):301-309. PubMed ID: 29102471
[TBL] [Abstract][Full Text] [Related]
42. Group 2 PH: Medical Therapy.
Guazzi M; Labate V
Prog Cardiovasc Dis; 2016; 59(1):71-7. PubMed ID: 27389809
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
De Vecchis R; Cesaro A; Ariano C
Minerva Cardioangiol; 2018 Oct; 66(5):659-670. PubMed ID: 28398017
[TBL] [Abstract][Full Text] [Related]
44. Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).
Dayeh NR; Ledoux J; Dupuis J
Prog Cardiovasc Dis; 2016; 59(1):11-21. PubMed ID: 27195752
[TBL] [Abstract][Full Text] [Related]
45. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
Ghio S; Crimi G; Pica S; Temporelli PL; Boffini M; Rinaldi M; Raineri C; Scelsi L; Pistono M; Totaro R; Guida S; Oltrona Visconti L
PLoS One; 2017; 12(11):e0188383. PubMed ID: 29176890
[TBL] [Abstract][Full Text] [Related]
46. [Pulmonary hypertension caused by left heart disease].
Erer B; Eren M
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():42-6. PubMed ID: 20819756
[TBL] [Abstract][Full Text] [Related]
47. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Huston JH; Shah SJ
Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
[TBL] [Abstract][Full Text] [Related]
48. Management of Pulmonary Hypertension in Left Heart Disease.
Macera F; Vachiéry JL
Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931
[TBL] [Abstract][Full Text] [Related]
49. Left Heart Disease-Related Pulmonary Hypertension.
Alamri AK; Ma CL; Ryan JJ
Cardiol Clin; 2022 Feb; 40(1):69-76. PubMed ID: 34809918
[TBL] [Abstract][Full Text] [Related]
50. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
Naeije R; D'Alto M
Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary hypertension with left-sided heart disease.
Guazzi M; Arena R
Nat Rev Cardiol; 2010 Nov; 7(11):648-59. PubMed ID: 20924360
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary hypertension associated with left-sided heart failure.
Adler J; Gerhardt F; Wissmüller M; Adler C; Baldus S; Rosenkranz S
Curr Opin Cardiol; 2020 Nov; 35(6):610-619. PubMed ID: 32969856
[TBL] [Abstract][Full Text] [Related]
53. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
Nagy AI; Venkateshvaran A; Merkely B; Lund LH; Manouras A
Eur J Heart Fail; 2017 Jan; 19(1):88-97. PubMed ID: 27748008
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary hypertension.
Shah SJ
JAMA; 2012 Oct; 308(13):1366-74. PubMed ID: 23032553
[TBL] [Abstract][Full Text] [Related]
55. [Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment].
Caravita S; Gori M; Garascia A; Baratto C; Camassa N; Carigi S; De Gennaro L; De Maria R; Enea I; Gentile P; Giordana F; Leonardi G; Lo Giudice F; Orso F; Romaniello A; Roncon L; Tinti MD; Vatrano M; Vedovati MC; Marini M; Picariello C
G Ital Cardiol (Rome); 2024 Feb; 25(2):88-97. PubMed ID: 38270364
[TBL] [Abstract][Full Text] [Related]
56. Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.
Nikolaidis L; Memon N; O'Murchu B
Tex Heart Inst J; 2015 Feb; 42(1):50-4. PubMed ID: 25873799
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease.
Howard C; Rangajhavala K; Safdar Z
Ther Adv Respir Dis; 2015 Apr; 9(2):35-41. PubMed ID: 25721948
[TBL] [Abstract][Full Text] [Related]
58. [Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010].
Rosenkranz S; Bonderman D; Buerke M; Felgendreher R; ten Freyhaus H; Grünig E; de Haan F; Hammerstingl C; Harreuter A; Hohenforst-Schmidt W; Kindermann I; Kindermann M; Kleber FX; Kuckeland M; Kübler WM; Mertens D; Mitrovic V; Opitz C; Schmeisser A; Schulz U; Speich R; Zeh W; Weil J;
Dtsch Med Wochenschr; 2010 Oct; 135 Suppl 3():S102-14. PubMed ID: 20862619
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
60. Pulmonary hypertension associated with left-sided heart disease.
Barnett CF; De Marco T
Heart Fail Clin; 2012 Jul; 8(3):447-59. PubMed ID: 22748905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
